MODULAR MEDICAL, INC.: 10-Q filed 2023-02-13
What MODULAR MEDICAL, INC. reported in its quarterly report filed 2023-02-13 (fiscal Q3 2023): 26 published measures, 76 facts as tagged in accession 0001019056-23-000132.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2023-02-13
- Fiscal period
- fiscal Q3 2023
- Accession
- 0001019056-23-000132 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MODULAR MEDICAL, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 8,738,842 | USD | |
| At 2022-03-31 | 9,846,446 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 715,297 | USD | |
| At 2022-03-31 | 1,009,656 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 8,023,545 | USD | |
| At 2022-09-30 | 10,742,524 | USD | |
| At 2022-06-30 | 13,450,491 | USD | |
| At 2022-03-31 | 8,836,790 | USD | |
| At 2021-12-31 | -8,246,635 | USD | |
| At 2021-09-30 | -5,100,814 | USD | |
| At 2021-06-30 | -1,581,488 | USD | |
| At 2021-03-31 | -1,275,149 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 7,690,957 | USD | |
| At 2022-03-31 | 9,076,372 | USD | |
| At 2021-12-31 | 204,098 | USD | |
| At 2021-03-31 | 1,468,465 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | -3,358,484 | USD | 92 |
| 2022-04-01 to 2022-12-31 | -10,307,682 | USD | 275 |
| 2022-07-01 to 2022-09-30 | -3,450,407 | USD | 92 |
| 2022-04-01 to 2022-06-30 | -3,498,791 | USD | 91 |
| 2021-10-01 to 2021-12-31 | -4,841,307 | USD | 92 |
| 2021-04-01 to 2021-12-31 | -14,058,154 | USD | 275 |
| 2021-07-01 to 2021-09-30 | -4,381,757 | USD | 92 |
| 2021-04-01 to 2021-06-30 | -4,835,091 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | -8,184,696 | USD | 275 |
| 2021-04-01 to 2021-12-31 | -7,128,787 | USD | 275 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | 573,066 | USD | 275 |
| 2021-04-01 to 2021-12-31 | 22,779 | USD | 275 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | 7,372,347 | USD | 275 |
| 2021-04-01 to 2021-12-31 | 5,887,199 | USD | 275 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | -573,066 | USD | 275 |
| 2021-04-01 to 2021-12-31 | -22,779 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | -44,887,453 | USD | |
| At 2022-03-31 | -34,579,771 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | 1,600 | USD | 275 |
| 2021-04-01 to 2021-12-31 | 1,600 | USD | 275 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 716,409 | USD | |
| At 2022-03-31 | 235,959 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-12-31 | 2,120,513 | USD | 275 |
| 2021-04-01 to 2021-12-31 | 2,740,086 | USD | 275 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | -3,357,897 | USD | 92 |
| 2022-04-01 to 2022-12-31 | -10,306,098 | USD | 275 |
| 2021-10-01 to 2021-12-31 | -3,831,064 | USD | 92 |
| 2021-04-01 to 2021-12-31 | -10,899,063 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 7,971,121 | USD | |
| At 2022-03-31 | 9,389,794 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-10-01 to 2021-12-31 | 1,010,247 | USD | 92 |
| 2021-04-01 to 2021-12-31 | 2,204,917 | USD | 275 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 715,297 | USD | |
| At 2022-03-31 | 969,699 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | 3,357,897 | USD | 92 |
| 2022-04-01 to 2022-12-31 | 10,306,098 | USD | 275 |
| 2021-10-01 to 2021-12-31 | 3,831,064 | USD | 92 |
| 2021-04-01 to 2021-12-31 | 10,899,063 | USD | 275 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | 2,196,546 | USD | 92 |
| 2022-04-01 to 2022-12-31 | 6,804,069 | USD | 275 |
| 2021-10-01 to 2021-12-31 | 1,849,399 | USD | 92 |
| 2021-04-01 to 2021-12-31 | 5,742,911 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 10,932,098 | shares | |
| At 2022-03-31 | 10,461,898 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 52,900,066 | USD | |
| At 2022-03-31 | 43,406,099 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 51,312 | USD | |
| At 2022-03-31 | 120,693 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 1,054,722 | USD | |
| At 2022-03-31 | 485,555 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 338,313 | USD | |
| At 2022-03-31 | 249,596 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | -3,358,484 | USD | 92 |
| 2022-04-01 to 2022-12-31 | -10,306,082 | USD | 275 |
| 2021-10-01 to 2021-12-31 | -4,841,307 | USD | 92 |
| 2021-04-01 to 2021-12-31 | -14,056,554 | USD | 275 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-10-01 to 2022-12-31 | 1,161,351 | USD | 92 |
| 2022-04-01 to 2022-12-31 | 3,502,029 | USD | 275 |
| 2021-10-01 to 2021-12-31 | 1,981,665 | USD | 92 |
| 2021-04-01 to 2021-12-31 | 5,156,152 | USD | 275 |
Inspect the source
- Entity
- MODULAR MEDICAL, INC. / CIK 0001074871
- Captured
- 2026-09-20T05:20:05.018Z
- SEC response SHA-256
35d9c7a349fec6383baca56e8aa4820d6d19d2f4955371898b75285f3bf308e4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001074871.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))